Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000900356 | SCV001044671 | likely benign | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000900356 | SCV001827526 | benign | not provided | 2019-05-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002537535 | SCV003683660 | uncertain significance | Inborn genetic diseases | 2022-06-29 | criteria provided, single submitter | clinical testing | The c.2023G>A (p.A675T) alteration is located in exon 14 (coding exon 14) of the XPR1 gene. This alteration results from a G to A substitution at nucleotide position 2023, causing the alanine (A) at amino acid position 675 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |